vs
Assertio Holdings, Inc.（ASRT）与SOLESENCE, INC.（SLSN）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是SOLESENCE, INC.的1.1倍（$13.5M vs $12.5M），SOLESENCE, INC.同比增速更快（-0.7% vs -57.9%），过去两年SOLESENCE, INC.的营收复合增速更高（12.5% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
ASRT vs SLSN — 直观对比
营收规模更大
ASRT
是对方的1.1倍
$12.5M
营收增速更快
SLSN
高出57.2%
-57.9%
两年增速更快
SLSN
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $12.5M |
| 净利润 | — | $163.0K |
| 毛利率 | — | 27.5% |
| 营业利润率 | -86.7% | 1.5% |
| 净利率 | — | 1.3% |
| 营收同比 | -57.9% | -0.7% |
| 净利润同比 | — | 129.2% |
| 每股收益（稀释后） | $-4.54 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTSLSN
| Q4 25 | $13.5M | $12.5M | ||
| Q3 25 | $49.5M | $14.6M | ||
| Q2 25 | $29.2M | $20.4M | ||
| Q1 25 | $26.5M | $14.6M | ||
| Q4 24 | $32.2M | $12.6M | ||
| Q3 24 | $29.2M | $16.9M | ||
| Q2 24 | $31.1M | $13.0M | ||
| Q1 24 | $32.4M | $9.9M |
净利润ASRTSLSN
| Q4 25 | — | $163.0K | ||
| Q3 25 | $11.4M | $-1.1M | ||
| Q2 25 | $-16.4M | $2.7M | ||
| Q1 25 | $-13.5M | $80.0K | ||
| Q4 24 | — | $-559.0K | ||
| Q3 24 | $-2.9M | $3.0M | ||
| Q2 24 | $-3.7M | $856.0K | ||
| Q1 24 | $-4.5M | $893.0K |
毛利率ASRTSLSN
| Q4 25 | — | 27.5% | ||
| Q3 25 | — | 23.1% | ||
| Q2 25 | — | 28.9% | ||
| Q1 25 | — | 23.1% | ||
| Q4 24 | — | 22.0% | ||
| Q3 24 | — | 36.2% | ||
| Q2 24 | — | 28.7% | ||
| Q1 24 | — | 36.3% |
营业利润率ASRTSLSN
| Q4 25 | -86.7% | 1.5% | ||
| Q3 25 | 23.2% | -5.4% | ||
| Q2 25 | -27.5% | 9.4% | ||
| Q1 25 | -50.0% | 1.8% | ||
| Q4 24 | -41.9% | -1.8% | ||
| Q3 24 | -10.4% | 19.0% | ||
| Q2 24 | -11.6% | 8.0% | ||
| Q1 24 | -13.4% | 11.3% |
净利率ASRTSLSN
| Q4 25 | — | 1.3% | ||
| Q3 25 | 23.1% | -7.7% | ||
| Q2 25 | -56.0% | 13.1% | ||
| Q1 25 | -51.1% | 0.5% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | -10.0% | 18.1% | ||
| Q2 24 | -11.8% | 6.6% | ||
| Q1 24 | -13.9% | 9.0% |
每股收益（稀释后）ASRTSLSN
| Q4 25 | $-4.54 | $0.00 | ||
| Q3 25 | $0.11 | $-0.02 | ||
| Q2 25 | $-0.17 | $0.04 | ||
| Q1 25 | $-0.14 | $0.00 | ||
| Q4 24 | $-3.28 | $0.00 | ||
| Q3 24 | $-0.03 | $0.04 | ||
| Q2 24 | $-0.04 | $0.01 | ||
| Q1 24 | $-0.05 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $1.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $17.6M |
| 总资产 | $267.0M | $50.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTSLSN
| Q4 25 | $63.4M | $1.3M | ||
| Q3 25 | $93.4M | $429.0K | ||
| Q2 25 | $98.2M | $4.1M | ||
| Q1 25 | $87.3M | $1.8M | ||
| Q4 24 | $100.1M | $1.4M | ||
| Q3 24 | $88.6M | $2.9M | ||
| Q2 24 | $88.4M | $2.4M | ||
| Q1 24 | $80.7M | $2.0M |
总债务ASRTSLSN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTSLSN
| Q4 25 | $94.0M | $17.6M | ||
| Q3 25 | $105.8M | $17.2M | ||
| Q2 25 | $93.3M | $18.2M | ||
| Q1 25 | $108.5M | $15.2M | ||
| Q4 24 | $121.1M | $14.9M | ||
| Q3 24 | $130.5M | $15.2M | ||
| Q2 24 | $132.2M | $11.9M | ||
| Q1 24 | $134.5M | $5.0M |
总资产ASRTSLSN
| Q4 25 | $267.0M | $50.1M | ||
| Q3 25 | $319.8M | $54.0M | ||
| Q2 25 | $273.8M | $60.0M | ||
| Q1 25 | $286.4M | $57.0M | ||
| Q4 24 | $284.7M | $50.0M | ||
| Q3 24 | $276.0M | $48.0M | ||
| Q2 24 | $279.4M | $40.8M | ||
| Q1 24 | $282.0M | $38.5M |
负债/权益比ASRTSLSN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $1.8M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 11.16× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASRTSLSN
| Q4 25 | $-30.0M | $1.8M | ||
| Q3 25 | $-4.8M | $-2.5M | ||
| Q2 25 | $19.1M | $-654.0K | ||
| Q1 25 | $-12.5M | $-7.2M | ||
| Q4 24 | $11.5M | $2.2M | ||
| Q3 24 | $-35.0K | $4.2M | ||
| Q2 24 | $7.4M | $-565.0K | ||
| Q1 24 | $7.5M | $-3.9M |
自由现金流ASRTSLSN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-404.0K | ||
| Q3 24 | — | $2.8M | ||
| Q2 24 | — | $-1.0M | ||
| Q1 24 | — | $-3.9M |
自由现金流率ASRTSLSN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.2% | ||
| Q3 24 | — | 16.6% | ||
| Q2 24 | — | -8.0% | ||
| Q1 24 | — | -39.9% |
资本支出强度ASRTSLSN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 20.6% | ||
| Q3 24 | 0.0% | 8.3% | ||
| Q2 24 | — | 3.7% | ||
| Q1 24 | — | 0.9% |
现金转化率ASRTSLSN
| Q4 25 | — | 11.16× | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | -0.25× | ||
| Q1 25 | — | -90.26× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.38× | ||
| Q2 24 | — | -0.66× | ||
| Q1 24 | — | -4.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
SLSN
暂无分部数据
